KIF18A-INHIBITOREN

Patent europeic · EP4007752 · En vigur

Inscripziun en il register

Numer da publicaziun: EP4007752
Numer da la dumonda: EP20757196
Gener: Patent europeic cun effect per la Svizra ed il Liechtenstein
Status: En vigur
Scrittira da patent: Concedì
Annunzià: 03-08-2020
Publitgà: 08-06-2022
Concedì: 24-09-2025
La protecziun finescha il pli tard: 02-08-2040
Proxima taxa annuala scadenta: 31-08-2027
Classas IPC: C07D 221/20 (2006.01)
C07D 401/12 (2006.01)
C07D 405/12 (2006.01)
C07D 409/12 (2006.01)
C07D 413/12 (2006.01)
A61P 35/00 (2006.01)
A61K 31/438 (2006.01)
Prioritad: US 201962882255 P 02.08.2019
Dumonda PCT: PCT/US2020/044797 03.08.2020
Publicaziun PCT: WO2021/026098 11.02.2021
Lingua da l’annunzia: englais
Funtauna: Swissreg

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

01-09-2026
Next annual fee due on
Next annual fee due on
31.08.2026 → 31.08.2027
Published in Swissreg on 01.09.2026
05-08-2026
Midada
Published in Swissreg on 05.08.2026
24-09-2025
Concedì
Specification status
Non-published patent application → Granted patent
Status of protective title
Initiated → Active
Published in Swissreg on 24.09.2025

One Amgen Center Drive Mail Stop 28-5-A, Thousand Oaks, California 91320-1799, US